12:00 AM
 | 
Dec 23, 2013
 |  BC Week In Review  |  Company News  |  Other News

Kairos Therapeutics, Centre for Drug Research and Development cancer news

Centre for Drug Research and Development’s (CDRD) commercialization vehicle, CDRD Ventures Inc., spun off Kairos to develop next-generation antibody-drug conjugate (ADC) therapeutics for cancer. CDRD Ventures granted Kairos an exclusive license to toxin and...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >